Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07076160 · ClinicalTrials.gov registry record · NA
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
A NA study of Presbyopia and Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 7
- Study locations
NCT07076160 is a NA study of Presbyopia and Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 74 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (72% lower). The trial reports 7 study locations across 4 states.
The verdict
NCT07076160, a NA study of Presbyopia and Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a 6-visit, single-masked, multi-site, 2×3 crossover, randomized-controlled, dispensing clinical trial to evaluate visual acuity.
Conditions Studied
Interventions
- DEVICE INFUSE® One Day Multifocal
- DEVICE ACUVUE® OASYS MAX 1-Day Multifocal Contact Lens
Study Locations (7)
Florida
- Dr. James Weber & Associates, PA - City Square Blvd - Jacksonville
- VRC - Jacksonville
- Pearson Research Center, PA - Longwood
- Maitland Vision Center - North Orlando Ave - Maitland
New York
- Sacco Eye Group - Vestal
Ohio
- Luxe Vision and Optical - Powell
Rhode Island
- Dr. David W. Ferris & Associates - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2025-07-24 |
| Est. Completion | 2025-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07076160
The ClinicalTrials.gov registry entry for NCT07076160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (72% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which INFUSE® One Day Multifocal is the first listed.
NCT07076160 reports 7 study locations spanning 4 distinct geographic areas - top geographies include Florida, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT07076160 about?
NCT07076160 is a clinical study titled "Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses". This is a 6-visit, single-masked, multi-site, 2×3 crossover, randomized-controlled, dispensing clinical trial to evaluate visual acuity.
What is the current status of trial NCT07076160?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2025-07-24. Estimated completion is 2025-09-20.
What conditions does trial NCT07076160 study?
This clinical trial studies the following conditions: Presbyopia, Visual Acuity.
What interventions are being tested in trial NCT07076160?
The interventions under investigation include: INFUSE® One Day Multifocal (DEVICE), ACUVUE® OASYS MAX 1-Day Multifocal Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT07076160?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07076160 being conducted?
This trial has 7 study locations across Florida, New York, Ohio, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.